SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 27th, 2022 • Allovir, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 27th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July 26, 2022, between AlloVir, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns a “Purchaser” and collectively the “Purchasers”).